NIH-funded research U01 cooperative agreement

Innate immune sensing and genetic links to kidney transplant outcomes

Official title: Innate allorecognition and KIR/LILR/HLA associations in kidney transplantation

Funded at Stanford University · NIH-11401445 · Data updated 2026-11-12

This grant looks at how innate immune receptors and genetic variations relate to long-term kidney transplant success in diverse patients.

More Kidney Transplantation research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 22, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$454,177
NIH project number5U01AI191596-02
Project IDNIH-11401445 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have received kidney transplants from diverse populations and are part of the included cohorts (roughly 2,000 donor/recipient pairs).

Less likely to help

Patients not eligible for these specific donor/recipient pairs or those without available genetic data may not benefit.

What this research studies

Researchers at Stanford will study how innate immune sensing of the transplanted kidney by NK cells and monocytes, through HLA, KIR, and LILR interactions, influences chronic rejection. They will sequence donor and recipient DNA to map high-resolution HLA and KIR/LILR types in about 2,000 kidney transplant pairs from North American and French cohorts. The study includes genomic analyses to infer ancestry and relatedness, plus analyses of immune cells in blood and allografts to uncover mechanisms. The project combines genetic data with clinical outcomes to identify factors linked to graft longevity.

Why it matters

Potential benefit: Finding genetic and immune factors linked to better graft survival could guide personalized donor-recipient matching and new therapies to reduce chronic rejection.

How similar studies have gone: Previous work supports the role of HLA and NK cell interactions in transplantation, but this study expands to comprehensive KIR/LILR typing and diverse cohorts.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Lakkis, Fadi G. — Stanford University
  • Study coordinator: Lakkis, Fadi G.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.